Prosecution Insights
Last updated: August 17, 2026

Examiner: SU-TOBON, QIWEN NMN

Tech Center 1600 • Art Units: 1600 1636

This examiner grants 75% of resolved cases

Performance Statistics

75.0%
Allow Rate
+15.0% vs TC avg
35
Total Applications
+100.0%
Interview Lift
1110
Avg Prosecution Days
Based on 4 resolved cases, 2023–2026

Rejection Statute Breakdown

5.2%
§101 Eligibility
8.5%
§102 Novelty
36.6%
§103 Obviousness
26.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17800417 COMPOSITIONS AND METHODS FOR IDENTIFYING HOST CELL TARGET PROTEINS FOR TREATING RNA VIRUS INFECTIONS Non-Final OA The Regents of the University of California
16972740 AAV CARDIAC GENE THERAPY FOR CARDIOMYOPATHY Non-Final OA University of Florida Research Foundation, Incorporated
17928028 MODULAR PLATFORM FOR PROGRAMMABLE SPATIOTEMPORAL BIOMOLECULE CLUSTERING WITH APPLICATIONS INCLUDING ENHANCED METABOLIC YIELD Non-Final OA The Trustees of Princeton University
18030324 T-DNA MEDIATED GENETIC MODIFICATION Final Rejection MASSACHUSETTS INSTITUTE OF TECHNOLOGY

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month